JOURNETA

Welcome to the Brand page for “JOURNETA”, which is offered here for Pharmaceutical preparations, pharmaceutical preparations for the prevention and treatment of obesity; dietetic preparations for medical use, dietary supplements; hydrogel for medical purposes; pharmaceutical preparations and substances for the treatment of glycemic control, obesity and constipation; pharmaceutical preparations, pharmaceutical preparations for use in the treatment of nonalcoholic steatohepatitis, nonalcoholic fatty liver disease, and inflammatory bowel disease; pharmaceutical preparations for gut and liver health; pharmaceutical preparations for treatment of overweight; pharmaceutical preparations for treatment of type 2 diabetes and pre-diabetes; herbal supplements; dietary supplements; vitamin supplements; probiotic supplements; nutritional supplements; weight management supplements;medical devices for use in the treatment of weight management; medical devices for use in the treatment of glycemic control, obesity and constipation; medical devices for use in the treatment of nonalcoholic steatohepatitis, nonalcoholic fatty liver disease, and inflammatory bowel disease; medical devices for use in the treatment of overweight; medical devices for gut and liver health; medical devices for use in the treatment of type 2 diabetes and pre-diabetes;.

Its status is currently believed to be active. Its class is unavailable. “JOURNETA” is believed to be currently owned by “Gelesis, Inc.”